The Discounted Cash Flow (DCF) valuation of Prometheus Biosciences Inc (RXDX) is (20.24) USD. With the latest stock price at 199.92 USD, the upside of Prometheus Biosciences Inc based on DCF is -110.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.6% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (56.85) - (12.01) | (20.24) |
| Upside | -128.4% - -106.0% | -110.1% |